Biopharmas raising money in public or private financings, including: Aquestive, Cancer Genetics, Forte, Fountain Healthcare, Inhibikase, Jiya, Massive Bio, Quantum Genomics, Scholar Rock, Ultragenyx.

Quarterly snapshots from biopharma companies with marketed products, including: GW, Jazz.

New hires and promotions in the biopharma industry, including: Ascendis, Durect, Excision, Exevir, Harpoon, Ibio, Trillium.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Brighter.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1health.io, Aseptiscope, Becton, Dickinson and Co., Butterfield Engineering, Certtech, China Grand Pharmaceutical and Healthcare Holdings, Dante Labs, Drawbridge Health, Exagen, Fluidigm, Healthcare Merger Corp., Heraeus Medical Components, Hologic, Hygea, Implantica, Lidco, Masimo, Mimedx, Parexel, Polarityte, Poseida Therapeutics, Pulse Systems, Soc Telemed, Synexa Life Sciences, Telix Pharmaceuticals.

Med-tech firms raising money in public or private financings, including: Biodesix, Novocure.

New hires and promotions in the med-tech industry, including: Myomo, Nortech, Soliton.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CSL, DBV, Chiesi, Imugene, Innocare, Innovation, Janssen, Neuraly, Pharmaxis, Polarityte, Poseida, Provention, Roche, Senhwa, Taigen.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adamas, Addex, Amphilix, Astrazeneca, Augmenta, Biospecifics, Blue Water, Calithera, Checkpoint, China Grand Pharmaceutical, CNS Pharmaceuticals, Daewoong, Decibel, Endo, Eurofins, Fusion, Genequantum, Hillstream, Horizon, Indivior, Isofol, Janssen, JT Pharmaceuticals, Mylan, Mymetics, Novavax, Ocuphire, Pfizer, Prevail, Recombinetics, Regulus, Rexahn, Samsung Biologics, Sanofi, Santhera, SK Biopharmaceuticals, Telix, Tempus, TFF, Titan, Zucara.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agenus, Aim, Aivita, Aligos, Arcutis, Astrazeneca, Curevac, Daiichi, Eli Lilly, Gritstone, Humanigen, Immunic, Incyte, Jounce, Mindmed, Novartis, Resverlogix, Revimmune, Rhythm, Shionogi, Sun, Symvivo, Tetra, Tiziana, UCB, Ultimovacs.